| Linda Sue Blinkmann, MSW, LISW | |
|
829 Chief Eddie Hoffman Highway, Suite 150, Bethel, AK 99559-0528 | |
| (907) 543-6100 | |
| (907) 543-6159 |
| Full Name | Linda Sue Blinkmann |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 829 Chief Eddie Hoffman Highway, Bethel, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346209087 | NPI | - | NPPES |
| 1020986 | Medicaid | AK | |
| 1006017 | Medicaid | AK | |
| 1584987 | Medicaid | AK |
| Entity Name | Pine Rest Christian Mental Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326117805 PECOS PAC ID: 4981506508 Enrollment ID: O20040127001144 |
News Archive
BioSante Pharmaceuticals, Inc., today announced completion of enrollment in its ongoing LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.
A large proportion of eligible NHS hospital trusts seem to be meeting the UK government target for setting up stroke units, but in name only, suggests a national audit, published in Quality and Safety in Health Care.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
The Paul G. Allen Family Foundation announced today it has awarded a $9.25 million grant to Penn researchers to study the underlying mechanisms of concussion and help uncover potential clinical interventions that could improve recovery.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Linda Sue Blinkmann, MSW, LISW Po Box 528, Attn: Bh Emergency Services, Bethel, AK 99559-0528 Ph: (907) 543-6100 | Linda Sue Blinkmann, MSW, LISW 829 Chief Eddie Hoffman Highway, Suite 150, Bethel, AK 99559-0528 Ph: (907) 543-6100 |
News Archive
BioSante Pharmaceuticals, Inc., today announced completion of enrollment in its ongoing LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.
A large proportion of eligible NHS hospital trusts seem to be meeting the UK government target for setting up stroke units, but in name only, suggests a national audit, published in Quality and Safety in Health Care.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
The Paul G. Allen Family Foundation announced today it has awarded a $9.25 million grant to Penn researchers to study the underlying mechanisms of concussion and help uncover potential clinical interventions that could improve recovery.
› Verified 1 days ago
Ora Lew Lowery, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddy Hoffman Hwy, Bethel, AK 99559 Phone: 907-543-6100 Fax: 907-543-6800 | |
Kristian Gallegos, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddie Hoffman, Bethel, AK 99559 Phone: 907-543-6100 Fax: 907-543-6159 | |
Ms. Joan P. Dewey, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: #23 Trailer Park, Airport Road, Bethel, AK 99559 Phone: 907-543-5885 Fax: 907-543-5885 | |
Julia Bragg, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddie Hoffman Hwy, Bethel, AK 99559 Phone: 907-543-6100 Fax: 907-543-6008 | |
Mr. Mohamed Ziauddin, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 324 Radio Street, Attn: Bh Patc Program, Bethel, AK 99559 Phone: 907-543-6730 Fax: 907-543-6712 | |
Rebecca Lee Lanham, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1410 Calista Drive, Bethel, AK 99559 Phone: 907-543-6730 Fax: 907-543-6712 | |
Diane M Mceachern, MSW,LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 829 Chief Eddie Hoffman, Bethel, AK 99559 Phone: 907-543-6101 |